Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 3, 2023 00:19 UTC |
Boudreau Philip PVICE PRESIDENT
|
Tax withholdingCommon shares without par value | 1,477 | $99.77 | $147,360.29 |
DisclosureSEC source: 0001415889-23-003894 · form4-03032023_120354.xml · nonDerivative · entry 1 Boudreau Philip P · CIK 0001805099 · VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,447 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:22 UTC |
Calamari Christopher J.SENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 2,827 | $99.77 | $282,049.79 |
DisclosureSEC source: 0001415889-23-003896 · form4-03032023_120343.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,822 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:23 UTC |
CAPEK JOHN MEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 6,247 | $99.77 | $623,263.19 |
DisclosureSEC source: 0001415889-23-003897 · form4-03032023_120325.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,443 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:25 UTC |
DALE MICHAEL DSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 4,942 | $99.77 | $493,063.34 |
DisclosureSEC source: 0001415889-23-003899 · form4-03032023_120339.xml · nonDerivative · entry 1 DALE MICHAEL D · CIK 0001172346 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,342 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:27 UTC |
Earnhardt Lisa DEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 7,631 | $99.77 | $761,344.87 |
DisclosureSEC source: 0001415889-23-003901 · form4-03032023_120327.xml · nonDerivative · entry 1 Earnhardt Lisa D · CIK 0001530893 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,380 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:30 UTC |
Ford Robert BDirector · CHAIRMAN AND CEO
|
Tax withholdingCommon shares without par value | 30,742 | $99.77 | $3,067,129.34 |
DisclosureSEC source: 0001415889-23-003904 · form4-03032023_120329.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,337 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:35 UTC |
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 11,500 | $99.77 | $1,147,355.00 |
DisclosureSEC source: 0001415889-23-003907 · form4-03032023_120303.xml · nonDerivative · entry 1 Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,501 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:36 UTC |
Ginascol John FEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 6,859 | $99.77 | $684,322.43 |
DisclosureSEC source: 0001415889-23-003908 · form4-03032023_120322.xml · nonDerivative · entry 1 Ginascol John F · CIK 0001778075 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,323 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:38 UTC |
Karam SammySENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 692 | $99.77 | $69,040.84 |
DisclosureSEC source: 0001415889-23-003909 · form4-03032023_120321.xml · nonDerivative · entry 2 Karam Sammy · CIK 0001766718 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,092 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:38 UTC |
Karam SammySENIOR VICE PRESIDENT
|
GrantCommon shares without par value | 12,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003909 · form4-03032023_120321.xml · nonDerivative · entry 1 Karam Sammy · CIK 0001766718 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,784 F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:40 UTC |
MANNING JOSEPH JEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 5,438 | $99.77 | $542,549.26 |
DisclosureSEC source: 0001415889-23-003910 · form4-03032023_120319.xml · nonDerivative · entry 1 MANNING JOSEPH J · CIK 0001695686 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,662 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:43 UTC |
Mateus FernandoSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 1,024 | $99.77 | $102,164.48 |
DisclosureSEC source: 0001415889-23-003911 · form4-03032023_120355.xml · nonDerivative · entry 1 Mateus Fernando · CIK 0001895703 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,857 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:45 UTC |
Moreland Mary KEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 5,926 | $99.77 | $591,237.02 |
DisclosureSEC source: 0001415889-23-003912 · form4-03032023_120314.xml · nonDerivative · entry 1 Moreland Mary K · CIK 0001783147 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,941 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:47 UTC |
Morrone Louis H.SENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 2,534 | $99.77 | $252,817.18 |
DisclosureSEC source: 0001415889-23-003913 · form4-03032023_120307.xml · nonDerivative · entry 1 Morrone Louis H. · CIK 0001867666 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,748 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:49 UTC |
PEDERSON MICHAEL JSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 3,522 | $99.77 | $351,389.94 |
DisclosureSEC source: 0001415889-23-003914 · form4-03032023_120318.xml · nonDerivative · entry 1 PEDERSON MICHAEL J · CIK 0001712233 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,156 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:52 UTC |
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 9,002 | $99.77 | $898,129.54 |
DisclosureSEC source: 0001415889-23-003916 · form4-03032023_120315.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,946 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:55 UTC |
Tyler Julie L.SENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 1,209 | $99.77 | $120,621.93 |
DisclosureSEC source: 0001415889-23-003918 · form4-03032023_120300.xml · nonDerivative · entry 1 Tyler Julie L. · CIK 0001867573 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,687 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:57 UTC |
Wainer Andrea FEXECUTIVE VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 7,531 | $99.77 | $751,367.87 |
DisclosureSEC source: 0001415889-23-003921 · form4-03032023_120354.xml · nonDerivative · entry 1 Wainer Andrea F · CIK 0001778070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,106 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:59 UTC |
Watkin JaredSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 5,598 | $99.77 | $558,512.46 |
DisclosureSEC source: 0001415889-23-003922 · form4-03032023_120354.xml · nonDerivative · entry 1 Watkin Jared · CIK 0001645118 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,564 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 01:01 UTC |
Wellisch Alejandro DSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 3,730 | $99.77 | $372,142.10 |
DisclosureSEC source: 0001415889-23-003925 · form4-03032023_010321.xml · nonDerivative · entry 2 Wellisch Alejandro D · CIK 0001717526 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,752 Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 01:01 UTC |
Wellisch Alejandro DSENIOR VICE PRESIDENT
|
GrantCommon shares without par value | 10,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003925 · form4-03032023_010321.xml · nonDerivative · entry 1 Wellisch Alejandro D · CIK 0001717526 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,482 F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 01:04 UTC |
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 4,123 | $99.77 | $411,351.71 |
DisclosureSEC source: 0001415889-23-003926 · form4-03032023_010311.xml · nonDerivative · entry 1 WOODGRIFT RANDEL WILLIAM · CIK 0001204554 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,235 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 00:20 UTC |
Tyler Julie L.SENIOR VICE PRESIDENT
|
SaleCommon shares without par value | 260 | $103.24 | $26,842.40 |
DisclosureSEC source: 0001415889-23-003064 · form4-02232023_120213.xml · nonDerivative · entry 4 Tyler Julie L. · CIK 0001867573 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,896 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 00:03 UTC |
Mateus FernandoSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 664 | $106.74 | $70,875.36 |
DisclosureSEC source: 0001415889-23-003056 · form4-02232023_120236.xml · nonDerivative · entry 3 Mateus Fernando · CIK 0001895703 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,881 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 00:20 UTC |
Tyler Julie L.SENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 341 | $106.74 | $36,398.34 |
DisclosureSEC source: 0001415889-23-003064 · form4-02232023_120213.xml · nonDerivative · entry 3 Tyler Julie L. · CIK 0001867573 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,156 Read SEC document |
| February 19, 2023 Filed Feb 23, 2023 00:03 UTC |
Mateus FernandoSENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 518 | $106.74 | $55,291.32 |
DisclosureSEC source: 0001415889-23-003056 · form4-02232023_120236.xml · nonDerivative · entry 2 Mateus Fernando · CIK 0001895703 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,545 Read SEC document |
| February 19, 2023 Filed Feb 23, 2023 00:20 UTC |
Tyler Julie L.SENIOR VICE PRESIDENT
|
Tax withholdingCommon shares without par value | 291 | $106.74 | $31,061.34 |
DisclosureSEC source: 0001415889-23-003064 · form4-02232023_120213.xml · nonDerivative · entry 2 Tyler Julie L. · CIK 0001867573 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,497 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:34 UTC |
Ahlberg Gregory ASENIOR VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 37,483 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003044 · form4-02222023_110235.xml · derivative · entry 3 Ahlberg Gregory A · CIK 0001826317 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,483 Underlying: Common Shares · 37,483 shares Expires 2033-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,494 on February 17, 2024, 12,494 on February 17, 2025, and 12,495 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:34 UTC |
Ahlberg Gregory ASENIOR VICE PRESIDENT
|
GrantCommon shares without par value | 9,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003044 · form4-02222023_110235.xml · nonDerivative · entry 1 Ahlberg Gregory A · CIK 0001826317 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,557 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:37 UTC |
ALLEN HUBERT LEXECUTIVE VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 72,754 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003045 · form4-02222023_110256.xml · derivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,754 Underlying: Common Shares · 72,754 shares Expires 2033-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,251 on February 17, 2024, 24,251 on February 17, 2025, and 24,252 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:37 UTC |
ALLEN HUBERT LEXECUTIVE VICE PRESIDENT
|
GrantCommon shares without par value | 18,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003045 · form4-02222023_110256.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,543 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:38 UTC |
Boudreau Philip PVICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 19,149 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003046 · form4-02222023_110238.xml · derivative · entry 3 Boudreau Philip P · CIK 0001805099 · VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,149 Underlying: Common Shares · 19,149 shares Expires 2033-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,383 on February 17, 2024, 6,383 on February 17, 2025, and 6,383 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:38 UTC |
Boudreau Philip PVICE PRESIDENT
|
GrantCommon shares without par value | 4,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003046 · form4-02222023_110238.xml · nonDerivative · entry 1 Boudreau Philip P · CIK 0001805099 · VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,924 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:40 UTC |
Calamari Christopher J.SENIOR VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 41,648 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003047 · form4-02222023_110207.xml · derivative · entry 4 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,648 Underlying: Common Shares · 41,648 shares Expires 2033-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,882 on February 17, 2024, 13,883 on February 17, 2025 and 13,883 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:40 UTC |
Calamari Christopher J.SENIOR VICE PRESIDENT
|
GrantCommon shares without par value | 10,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003047 · form4-02222023_110207.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,649 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:43 UTC |
CAPEK JOHN MEXECUTIVE VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 62,527 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003048 · form4-02222023_110254.xml · derivative · entry 2 CAPEK JOHN M · CIK 0001328034 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,527 Underlying: Common Shares · 62,527 shares Expires 2033-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,842 on February 17, 2024, 20,842 on February 17, 2025, and 20,843 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:43 UTC |
CAPEK JOHN MEXECUTIVE VICE PRESIDENT
|
GrantCommon shares without par value | 15,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003048 · form4-02222023_110254.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,690 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:46 UTC |
DALE MICHAEL DSENIOR VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 37,483 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003049 · form4-02222023_110249.xml · derivative · entry 2 DALE MICHAEL D · CIK 0001172346 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,483 Underlying: Common Shares · 37,483 shares Expires 2033-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,494 on February 17, 2024, 12,494 on February 17, 2025, and 12,495 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:46 UTC |
DALE MICHAEL DSENIOR VICE PRESIDENT
|
GrantCommon shares without par value | 9,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003049 · form4-02222023_110249.xml · nonDerivative · entry 1 DALE MICHAEL D · CIK 0001172346 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,284 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:48 UTC |
Earnhardt Lisa DEXECUTIVE VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 62,527 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003050 · form4-02222023_110253.xml · derivative · entry 2 Earnhardt Lisa D · CIK 0001530893 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,527 Underlying: Common Shares · 62,527 shares Expires 2033-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,842 on February 17, 2024, 20,842 on February 17, 2025, and 20,843 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:48 UTC |
Earnhardt Lisa DEXECUTIVE VICE PRESIDENT
|
GrantCommon shares without par value | 15,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003050 · form4-02222023_110253.xml · nonDerivative · entry 1 Earnhardt Lisa D · CIK 0001530893 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,011 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:50 UTC |
Ford Robert BDirector · CHAIRMAN AND CEO
|
GrantOption (right to buy) · Derivative | 276,082 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003051 · form4-02222023_110230.xml · derivative · entry 3 Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,082 Underlying: Common Shares · 276,082 shares Expires 2033-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 92,027 on February 17, 2024, 92,027 on February 17, 2025, and 92,028 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:50 UTC |
Ford Robert BDirector · CHAIRMAN AND CEO
|
GrantCommon shares without par value | 70,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003051 · form4-02222023_110230.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,079 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:53 UTC |
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 96,301 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003052 · form4-02222023_110236.xml · derivative · entry 6 Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,301 Underlying: Common Shares · 96,301 shares Expires 2033-02-16 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,100 on February 17, 2024, 32,100 on February 17, 2025, and 32,101 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:53 UTC |
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT
|
GrantCommon shares without par value | 24,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003052 · form4-02222023_110236.xml · nonDerivative · entry 1 Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,001 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:56 UTC |
Ginascol John FEXECUTIVE VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 56,275 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003053 · form4-02222023_110237.xml · derivative · entry 2 Ginascol John F · CIK 0001778075 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,275 Underlying: Common Shares · 56,275 shares Expires 2033-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,758 on February 17, 2024, 18,758 on February 17, 2025, and 18,759 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:56 UTC |
Ginascol John FEXECUTIVE VICE PRESIDENT
|
GrantCommon shares without par value | 14,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003053 · form4-02222023_110237.xml · nonDerivative · entry 1 Ginascol John F · CIK 0001778075 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,182 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:58 UTC |
Karam SammySENIOR VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 45,812 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003054 · form4-02222023_110235.xml · derivative · entry 1 Karam Sammy · CIK 0001766718 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,812 Underlying: Common Shares · 45,812 shares Expires 2033-02-16 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,270 on February 17, 2024, 15,271 on February 17, 2025, and 15,271 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 00:00 UTC |
MANNING JOSEPH JEXECUTIVE VICE PRESIDENT
|
GrantOption (right to buy) · Derivative | 62,527 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003055 · form4-02232023_120214.xml · derivative · entry 2 MANNING JOSEPH J · CIK 0001695686 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,527 Underlying: Common Shares · 62,527 shares Expires 2033-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,842 on February 17, 2024, 20,842 on February 17, 2025, and 20,843 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 00:00 UTC |
MANNING JOSEPH JEXECUTIVE VICE PRESIDENT
|
GrantCommon shares without par value | 15,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003055 · form4-02232023_120214.xml · nonDerivative · entry 1 MANNING JOSEPH J · CIK 0001695686 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,100 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.